| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(02)09420-5 |
| P698 | PubMed publication ID | 12126840 |
| P50 | author | Alistair Burns | Q37369113 |
| P2093 | author name string | Konrad Maurer | |
| E Jane Byrne | |||
| P2860 | cites work | Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial | Q28343193 |
| Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis. | Q33895786 | ||
| Auguste D and Alzheimer's disease | Q48705089 | ||
| Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. | Q50244904 | ||
| The effects of donepezil in Alzheimer's disease - results from a multinational trial. | Q53228615 | ||
| Alzheimer's disease. Unravelling the disease process. | Q53246006 | ||
| A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. | Q53341841 | ||
| P433 | issue | 9327 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 163-165 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Alzheimer's disease | |
| P478 | volume | 360 |
| Q59050978 | A Multi-centre Randomized Control Group Trial on the Use of Art Therapy for Older People with Dementia |
| Q35106666 | A systematic review of single chinese herbs for Alzheimer's disease treatment |
| Q41877527 | Aging and neurogenesis, a lesion from Alzheimer's disease. |
| Q35116978 | Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. |
| Q34154712 | Alzheimer and his disease: a brief history |
| Q28244902 | Apigenin and related compounds stimulate adult neurogenesis. Mars, Inc., the Salk Institute for Biological Studies: WO2008147483 |
| Q38034089 | Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease |
| Q37407141 | Beyond the rat models of human neurodegenerative disorders |
| Q50436666 | Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk |
| Q27023758 | Cerebrospinal fluid and blood biomarkers in Alzheimer's disease |
| Q52568314 | Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. |
| Q36334469 | Epidemiology of acute organophosphate poisoning in hospital emergency room patients |
| Q38742951 | Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases |
| Q46012375 | Fourteen compounds and their derivatives for the treatment of diseases and injuries characterized by reduced neurogenesis and neurodegeneration. Neuronascent, Inc.: WO2007035722. |
| Q51010634 | Granulocyte-colony stimulating factor protects memory impairment in the senescence-accelerated mouse (SAM)-P10. |
| Q36348325 | Is the Alzheimer's disease cortical thickness signature a biological marker for memory? |
| Q48722375 | Magnetic resonance imaging for monitoring neurogenesis in the adult hippocampus |
| Q46356448 | Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease |
| Q92518340 | Physiological and pathological effects of amyloid-β species in neural stem cell biology |
| Q35029390 | Platelets in psychiatric disorders |
| Q34342742 | Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age. |
| Q38107439 | Progress in stem cell therapy for major human neurological disorders. |
| Q47703114 | Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells |
| Q92641520 | Synthesis of New Quinoline-Piperonal Hybrids as Potential Drugs against Alzheimer's Disease |
| Q35754292 | Telomere length is age-dependent and reduced in monocytes of Alzheimer patients |
| Q38192009 | The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders |
| Q50936744 | The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro. |
| Q35607653 | Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects |
Search more.